Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage

Saved in:
Bibliographic Details
Published in:The FASEB journal 2001-08, Vol.15 (10), p.1822
Main Authors: Muller, D N, Heissmeyer, V, Dechend, R, Hampich, F, Park, J K, Fiebeler, A, Shagdarsuren, E, Theuer, J, Elger, M, Pilz, B, Breu, V, Schroer, K, Ganten, D, Dietz, R, Haller, H, Scheidereit, C, Luft, F C
Format: Article
Language:English
Subjects:
Angiotensin II
Angiotensinogen - genetics
Animals
Animals, Genetically Modified
Aspirin - administration & dosage
Aspirin - pharmacology
Aspirin - therapeutic use
CD4-Positive T-Lymphocytes - pathology
CD8-Positive T-Lymphocytes - pathology
Gene Expression
Heart Diseases - chemically induced
Heart Diseases - prevention & control
Humans
I-kappa B Kinase
Kidney - blood supply
Kidney - chemistry
Kidney Diseases - chemically induced
Kidney Diseases - prevention & control
Macrophages - pathology
Monocytes - pathology
Myocarditis - pathology
Myocarditis - prevention & control
Myocardium - chemistry
Nephritis - pathology
Nephritis - prevention & control
NF-kappa B - antagonists & inhibitors
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Rats
Renin - genetics
Transcription Factor AP-1 - antagonists & inhibitors
Vascular Cell Adhesion Molecule-1 - analysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0892-6638
DOI:10.1096/fj.00-0843fje